Answers are grounded in this paper and cite their sources.
In this trial involving patients with platinum-sensitive, recurrent ovarian cancer, secondary surgical cytoreduction followed by chemotherapy did not result in longer overall survival than chemotherapy alone. (Funded by the National Cancer Institute and others; GOG-0213 ClinicalTrials.gov number, NCT00565851.).
No takes yet. Share an insight, caveat, or question.
Coleman et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: